Signals mentioning Cipla
- Cipla and Rocket India commit ₹300 crore to Karnataka capacity expansion
- Cipla and Rocket India plan ₹300 crore Karnataka manufacturing expansion
- Cipla Health takes Prolyte ORS awareness campaign into hospitals, transit and trade
- Cipla prioritises Yurpeak as sales nearly double, delaying semaglutide launch
- Cipla’s India sales rise 12% as it leans on consumer-health expansion
- Cipla Q1FY27 profit falls 39% despite record India sales
- HDFC Securities sees FY27 consumer recovery, but input volatility clouds margins
- India pharma market grows 16% as drugmakers enter US tariff-free transition
- Vishal Mega Mart, Meesho slated to report Q1 FY27 results on July 23
- GTRI flags proposed US generic-drug tariffs as major risk for Indian pharma exporters
- Indian generic drugmakers face potential US tariff shock from 2028
- Indian pharma stocks slide as Trump outlines tariffs of up to 200% on generic drugs
- Cipla Health's Omnigel debuts first sub-brand Maxstrong in 2% diclofenac category
- Q2 FY25 earnings day: V-Mart, Marico, Vedant Fashions, Dabur report as RIL profit slips 4.8%
- Analysts flag strong buy on Kalyan Jewellers at Rs 377.85 on resilient domestic demand
- Zepto IPO draws Tendulkar, Bachchan, Agrawal as Rs 8,010 cr fresh issue lines up July listing
- Trent's 1:2 bonus, RIL Rs 6 dividend headline retail corporate-action calendar June 1-6
- Trent goes ex-bonus 1:2, RIL declares Rs 6 dividend in retail-heavy corp action week
- Jefferies sticks with Swiggy Buy at Rs 415, sees 49% upside as food delivery GOV grows 23%
- DCGI orders nationwide crackdown on illegal sildenafil, tadalafil sales across pharmacies and e-platforms